#c3gn - Twitter Hashtag

3 months ago

Every day in our Glomerular Disease Clinic, I see firsthand the toll that rare kidney disorders take on patients and families. #C3GN is one of those diseases that doesn’t get nearly enough attention yet its impact on quality of life and kidney survival is profound. See our latest paper on this topic here: https://t.co/TsWynqWwuX #KidneyDisease #Nephrology #C3Glomerulopathy #RareDisease #GlomerularDisease

0

18

3

0

812

Nissreen Elfadawy MD, MS, FASN, FAST @ElfadawyN

4 months ago

#NKF #NKFSCM26 @nkf #C3GN and new therapies. Vaccines and antibiotics before Complements inhibitors @kdjhaveri @anuja_java

1

7

1

572

Sayed S Rahman @SayedSRahman1

5 months ago

Finding the etiology of MPGN : The Algorthm modified by Dr Sethi . #DrSethi #C3GN #MPGN https://t.co/cvdUajpAyK

0

21

11

1K

Sayed S Rahman @SayedSRahman1

5 months ago

The Pecision Clinical Playbook: C3GN and DDD : Decoding complement pathway dysregulation, Differential diagnosis and instead of one size fit all, going for stepwise approach with horizon of targeted therapy . #C3GN #DDD

SayedSRahman1's tweet photo. The Pecision Clinical Playbook:
C3GN and DDD :
Decoding complement pathway dysregulation,
Differential diagnosis and instead of one size fit all, going for stepwise approach with horizon of targeted therapy .
#C3GN
#DDD https://t.co/fDdLKiMSaO

0

29

11

14

2K

HofNorthwell Kidney @HofstraKidney

8 months ago

Dr Sungsoo Kim @kdjhaveri and Dr Kuruvada on https://t.co/ecQ1afpoCd New Horizons in C3 Glomerulopathy: Targeted Complement Inhibition Arrives @asnpublications #kidneynews #c3GN

HofstraKidney's tweet photo. Dr Sungsoo Kim @kdjhaveri and Dr Kuruvada on https://t.co/ecQ1afpoCd New Horizons in C3 Glomerulopathy: Targeted Complement Inhibition Arrives @asnpublications #kidneynews #c3GN https://t.co/cgDXLgnPON

0

4

1

2

480

Dr Anant Pilawan MD DM 🇮🇳 CMC Vellore @Glomkeeper

9 months ago · Taipei City

⁉️Excited about where we’re headed with C3GN and my coursework 💡 — so many possibilities ahead. Looking forward to gaining new insights, pushing boundaries, and trying to shape the future of complement-mediated kidney diseases! By @DrSharonFord 🚀 #C3GN #MPGN

Glomkeeper's tweet photo. ⁉️Excited about where we’re headed with C3GN and my coursework 💡 — so many possibilities ahead. Looking forward to gaining new insights, pushing boundaries, and trying to shape the future of complement-mediated kidney diseases! By @DrSharonFord 🚀 #C3GN #MPGN https://t.co/MyQP6jLlZY

0

3

0

1

208

Christos Argyropoulos MD PhD 0kale/acc 🇺🇸 @ChristosArgyrop

10 months ago

Our #Covid19 work in #KidneyWk (can skip reading them as there is no condition in which covid is good for you): > transplant fx over time https://t.co/57hj38oWpG > kidney fx over time https://t.co/PoytqBfDVF > AKI https://t.co/oJ8SrzConC > #C3GN https://t.co/TjaX5pAfBK > #IgAN https://t.co/XeagGmyvtx > dialysis vasc access https://t.co/77o9SM4MKO

3

66

15

25

21K

MaFer Zavala

@Mafer_ZavalaM

11 months ago

Great session of #C3GN and case-based discussion in #GlomConHawaii!! 🔥 @JeanHouMD Dr. Carla Nester, Dr. Nicole Isbel @JohnSperati @SaynaNorouzi Dr. Samir Parikh @OrhanEfe_ Corey Cavanaugh. #C3GN #Complement 🌺#GlomConHawaii

Mafer_ZavalaM's tweet photo. Great session of #C3GN and case-based discussion in #GlomConHawaii!! 🔥

@JeanHouMD Dr. Carla Nester, Dr. Nicole Isbel @JohnSperati @SaynaNorouzi Dr. Samir Parikh @OrhanEfe_ Corey Cavanaugh.

#C3GN #Complement 🌺#GlomConHawaii https://t.co/zdkLn8Q1Px

0

13

2

610

MaFer Zavala

@Mafer_ZavalaM

11 months ago

Dr. @JohnSperati talking about his approach on #C3GN on #GlomConHawaii ✅ Exclude infection, M-Ig, masked heavy chains!! ✅ Evaluate drivers of disease ✅ Evaluate baseline prognosis (risk scores: Chaucer, GLOSEN) 💊New drugs: iptacopan, pegcetacopan ✅ Follow-up proteinuria goal of <0.88 g/g or ⬇️50% at 12mo #GlomConHawaii 🌺 @GlomCon

Mafer_ZavalaM's tweet photo. Dr. @JohnSperati talking about his approach on #C3GN on #GlomConHawaii

✅ Exclude infection, M-Ig, masked heavy chains!!
✅ Evaluate drivers of disease
✅ Evaluate baseline prognosis (risk scores: Chaucer, GLOSEN)
💊New drugs: iptacopan, pegcetacopan
✅ Follow-up proteinuria goal of <0.88 g/g or ⬇️50% at 12mo

#GlomConHawaii 🌺
@GlomCon

0

23

11

8

2K

American Society of Pediatric Nephrology @ASPNeph

12 months ago

Case report: De novo C3 Glomerulonephritis in a Kidney Transplant Recipient Associated with an Unreported CFH Variant @KIReports #openaccess #C3GN https://t.co/5BXgbXF0pV

0

11

6

1

822

Trisha Laxamana MD ❄️🗽🇵🇭 @NephroloTrish

over 1 year ago

Presented a case of C3 Glomerulonephritis #C3GN for fellow’s case conference @NYUnephro ✨ My favorite photos/diagrams from resources I used — highly educational!👇🏼 📚 https://t.co/1YOGGuyRzm 📚 https://t.co/1vAJY3QRfJ 📚 https://t.co/gGGV5Qt2Nv #glomerulardisease #nephrology

NephroloTrish's tweet photo. Presented a case of C3 Glomerulonephritis #C3GN for fellow’s case conference @NYUnephro ✨

My favorite photos/diagrams from resources I used — highly educational!👇🏼

📚 https://t.co/1YOGGuyRzm
📚 https://t.co/1vAJY3QRfJ
📚 https://t.co/gGGV5Qt2Nv

#glomerulardisease #nephrology https://t.co/ePkuoCjuLn

0

5

1

2

623

KIReports @KIReports

over 1 year ago

Challenges in the Diagnosis and Management of Immune Complex-Mediated Membranoproliferative Glomerulonephritis and Complement 3 Glomerulopathy https://t.co/cK3T0lN7rA #KIRReview #C3GN #ICMPGN

KIReports's tweet photo. Challenges in the Diagnosis and Management of Immune Complex-Mediated Membranoproliferative Glomerulonephritis and Complement 3 Glomerulopathy

https://t.co/cK3T0lN7rA

#KIRReview #C3GN #ICMPGN https://t.co/aCgmcyhGeB

0

47

18

31

4K

American Society of Pediatric Nephrology @ASPNeph

almost 2 years ago

Iptacopan reduces proteinuria and stabilizes kidney function in C3 glomerulopathy @KIREPORTS #C3GN https://t.co/FiA7BXPrlZ

0

15

4

3

745

Deirdre Bartlett, MD MS @d_m_bartlett

almost 2 years ago

Congrats on the @thePNRC @nephcure grant for your research @AnaSo_MD ! @lurie_nu so proud of you!! 💜 #C3GN

Priya Verghese @priyagoose

almost 2 years ago

Dr. Ana Solis knocking it out of the park with her study presentation ⁦@thePNRC⁩ #FallPNRCMeeting2024 #LurieNephFelllowsRock

priyagoose's tweet photo. Dr. Ana Solis knocking it out of the park with her study presentation ⁦@thePNRC⁩ #FallPNRCMeeting2024 #LurieNephFelllowsRock https://t.co/yLlyLZrngT

0

9

1

1K

1

8

0

338

American Society of Pediatric Nephrology @ASPNeph

about 2 years ago

Kidney transplantation in children and adolescents with C3 glomerulopathy or immune complex membranoproliferative glomerulonephritis: a real-world study within the CERTAIN research network https://t.co/uBxqcTkEC9 #C3GN #IC-MPGN

ASPNeph's tweet photo. Kidney transplantation in children and adolescents with C3 glomerulopathy or immune complex membranoproliferative glomerulonephritis: a real-world study within the CERTAIN research network

https://t.co/uBxqcTkEC9
#C3GN #IC-MPGN https://t.co/R0NGQxDr2J

0

13

4

2

1K

KIReports @KIReports

about 2 years ago

Clinical Remission and Reduction of Circulating Nephritic Factors by Combining #Rituximab With #Belimumab in a Case of Complement Factor 3 Glomerulopathy #KIRNephrologyRounds #C3GN

KIReports's tweet photo. Clinical Remission and Reduction of Circulating Nephritic Factors by Combining #Rituximab With #Belimumab in a Case of Complement Factor 3 Glomerulopathy

#KIRNephrologyRounds #C3GN https://t.co/go1dwS03nv

0

20

5

2K

Milagros Flores @dra_miliflores

over 2 years ago

Potencial del #ApoE en Glomerulopatía C3 #C3GN ✅Desregulación de algunas vías del complemento ✅Inflamación y lesión glomerular 👀 🔬ApoE 81.3% VVP 80% 📈 🗓️Tenemos una cita 💥#NephJC 💥Martes 4/23 9 pm EST 💥Miercoles 4/24 9pm IST @NephJC @AnvithaRangan 💥 @stephanietr612 💥